BMS China Expects To Double Sales Growth This Year Over Last
This article was originally published in PharmAsia News
The increase in China sales of drugs by Bristol-Myers Squibb this year is expected to be double that of last year, the head of BMS China said.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.